Perception of side effects associated with anticancer treatment in women with breast or ovarian cancer (KEM-GO-1): a prospective trial.

Beyhan AtasevenJohanna FrindtePhilipp HarterGudrun GebersCaroline VogtAlexander TrautElisabeth BreitVincenzo BluniMattea ReinischFlorian HeitzAthina KostaraSherko KuemmelSonia PraderMareike BommertStephanie SchneiderAndreas du Bois

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2019)

Sleep disturbances have lately emerged as the most severe problem in women with OC or BC receiving anticancer therapy. Concerns about family and partner were ranked second in the current study and first in previous investigations.

Keyphrases

clinical trial
study protocol
early onset
phase iii
randomized controlled trial
stem cells
depressive symptoms
hepatitis c virus
open label
cell therapy
men who have sex with men
double blind
chemotherapy induced